medical marijuana dispensaries
Recently Published Documents


TOTAL DOCUMENTS

31
(FIVE YEARS 12)

H-INDEX

8
(FIVE YEARS 3)

2020 ◽  
pp. 088626052091259
Author(s):  
Bridget Freisthler ◽  
Christiana Kranich

The changing legal status of marijuana in the United States has increased access to the drug through medical marijuana dispensaries. Limited research exists that examines the effects of these dispensaries on social problems including child maltreatment. The current study examines how medical marijuana dispensaries may affect referrals for child abuse and neglect investigations. Data are analyzed from 2,342 Census tracts in Los Angeles County, California. Locations of medical marijuana dispensaries were obtained through Weedmaps.com . Using conditionally autoregressive models, local and spatially lagged dispensaries show a positive relationship to rates of referrals in the unadjusted models. However, when we adjust for alcohol outlet density and measures of social disorganization, this relationship is no longer significant. Although this study does not find a relationship between medical marijuana dispensaries and referrals for investigations of child maltreatment, it should not be considered a definitive finding of this relationship. The increasing number of states that are allowing marijuana to be used for medical and recreational purposes is resulting in more people using the drug and the effects on parenting are still unknown.


Addiction ◽  
2019 ◽  
Vol 114 (12) ◽  
pp. 2162-2170 ◽  
Author(s):  
Regina A. Shih ◽  
Anthony Rodriguez ◽  
Layla Parast ◽  
Eric R. Pedersen ◽  
Joan S. Tucker ◽  
...  

2019 ◽  
Vol 54 (11) ◽  
pp. 1862-1874 ◽  
Author(s):  
Stephen E. Lankenau ◽  
Loni Philip Tabb ◽  
Avat Kioumarsi ◽  
Janna Ataiants ◽  
Ellen Iverson ◽  
...  

2019 ◽  
Vol 10 (2) ◽  
pp. 4
Author(s):  
Paul C Langley

In a previous commentary in INNOVATIONS in pharmacy, the question was raised as to the questions legislators should ask for the licensing of medical marijuana dispensaries. The case was made that if dispensaries accept they have a duty of care then they should be required to monitor patients over the course of their treatment with botanical cannabis, including hemp based product, to evaluate the response of patients to therapy. One option would be for individual dispensaries (or owners of multiple licenses and dispensary locations) to adopt a registry format and implement an on-line reporting system by registry staff and patients for the conditions being treated. Unfortunately, under present legislative rules for dispensaries there is no incentive for dispensaries to make the necessary investment. It is also unlikely that legislators would be prepared to mandate a registry requirement. The purpose of this commentary is to offer an alternative solution. Rather than dispensary specific registries, a state-wide low cost registry is proposed where dispensaries are required to log in and track patients with specific conditions. In the case of severe pain, a dispensary would log in patients presenting with this condition and the patient tracked over their course of treatment. A further advantage with a statewide registry is that if a patient visits a different dispensary they can still be tracked as they would be identified by their marijuana card number. The ability to track patients by condition, while still resident in a state, would not only minimize the issue of incomplete records, but would provide a comprehensive, research quality framework for evaluating claims for botanical cannabis. This could then provide feedback to legislators and establish a robust basis for rule making.   Article Type: Commentary


2019 ◽  
Vol 86 (1) ◽  
pp. 47-55 ◽  
Author(s):  
Ethan Schimmoeller

Ohio’s first medical marijuana dispensaries will open in the fall of 2018, so physicians, then, must decide whether they will participate. But is medical marijuana really medical? No, at best, it is an unproven botanical. Medicine today is progressively moving away from traditional understandings of health according to formal and final causation and toward wellness as an expanding, subjective ideal. Whereas patients are healthy if the doctor says so, patients are well if they say so. Pitched as a wellness product, cannabis presents itself as an existential palliative, part of an imminent cult of the body. Consequently, people often use cannabis to escape reality according to a new age mythos. Physicians can play their part by choosing not to certify for “medical” marijuana and seek to rediscover the body as more than mere dead matter in motion rather than insulating ourselves from the difficult questions of suffering, meaning, and purpose. Summary: Despite state-level legality, medical marijuana is not medical. Rather, it is often touted as part of a cult of the body to escape suffering and death.


2019 ◽  
Vol 10 (1) ◽  
pp. 2
Author(s):  
Paul Langley

A previous commentary in INNOVATIONS in Pharmacy argued that, given the lack of evidence for outcomes in medical marijuana, outside of a handful of randomized clinical trials and even fewer observational studies, good clinical practice points to the need for monitoring patients who received cannabis through certified medical marijuana dispensaries. The commentary noted the lack of standards for monitoring cannabis patients and the lack of feedback from the dispensary to providers. Botanical cannabis administration was occurring in, effectively, an evidence vacuum. More to the point, dispensary owners and investors seem uninterested in establishing a robust evidence base for cannabis outcomes.  Given the range of conditions and symptoms presented by patients, to include the prevalence of multiple symptoms together with the range of potential cannabis formulations, dosing regimens and delivery options, a failure to monitor patients over the course of their exposure to cannabis in not acceptable. The purpose of this commentary is to report on a proposed on-line registry structure proposed by Prometheus Research for medical marijuana dispensaries in the US. The registry tracks and reports on patients over the course of treatment with botanical cannabis with the focus on severe or chronic non-cancer pain, severe nausea, persistent muscle spasms and seizures, together with prevalent comorbidities – fatigue, anxiety, depression and sleep. This is the first time a registry has been developed for dispensaries in the United States as a model for a robust evidence base to support botanical cannabis as a therapy option.   Article Type: Commentary


Sign in / Sign up

Export Citation Format

Share Document